Literature DB >> 7646554

Degradation of 2-(3-aminopropylamino)-ethanethiol (WR-1065) by Cu-dependent amine oxidases and influence on glutathione status of Chinese hamster ovary cells.

T Meier1, R D Issels.   

Abstract

The radioprotective drug 2-(3-aminopropylamino)ethanethiol (WR-1065) can be degraded when incubated in cell culture medium in vitro. The degradation reaction consumes oxygen and results from the action of Cu-dependent amine oxidases present in the serum content of the medium. Analysis of the degradation products of WR-1065 demonstrates the formation of cysteamine, acrolein and H2O2. WR-2721, the inactive prodrug of WR-1065, is not a substrate for these enzymes. Extracellular degradation of WR-1065 by Cu-dependent amine oxidases leads to an intracellular depletion of glutathione (GSH) in Chinese hamster ovary (CHO) cells and to reduction of clonogenic cell survival. Addition of aminoguanidine, an inhibitor of Cu-dependent amine oxidases, protects CHO cells from the toxic effects of WR-1065 and under these conditions an increase of intracellular GSH levels occurs. These data demonstrate that WR-1065 can be degraded to toxic compounds by the presence of Cu-dependent amine oxidases which might have further implications for the clinical use of WR-2721.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7646554     DOI: 10.1016/0006-2952(95)00164-u

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  6 in total

1.  In vitro protection from cisplatin-induced neurotoxicity by amifostine and its metabolite WR1065.

Authors:  C C Verstappen; A A Geldof; T J Postma; J J Heimans
Journal:  J Neurooncol       Date:  1999-08       Impact factor: 4.130

2.  The cytoprotective drug amifostine modifies both expression and activity of the pro-angiogenic factor VEGF-A.

Authors:  S Dedieu; X Canron; H R Rezvani; M Bouchecareilh; F Mazurier; R Sinisi; M Zanda; M Moenner; A Bikfalvi; S North
Journal:  BMC Med       Date:  2010-03-24       Impact factor: 8.775

3.  Mammalian cell polyamine homeostasis is altered by the radioprotector WR1065.

Authors:  J L Mitchell; J Rupert; A Leyser; G G Judd
Journal:  Biochem J       Date:  1998-10-15       Impact factor: 3.857

4.  WR1065 mitigates AZT-ddI-induced mutagenesis and inhibits viral replication.

Authors:  Dale M Walker; Adriana E Kajon; Salina M Torres; Meghan M Carter; Consuelo L McCash; James A Swenberg; Patricia B Upton; Andrew W Hardy; Ofelia A Olivero; Gene M Shearer; Miriam C Poirier; Vernon E Walker
Journal:  Environ Mol Mutagen       Date:  2009-07       Impact factor: 3.216

5.  Culture medium enhances semicarbazide-sensitive amine oxidase activity.

Authors:  M B Trent; D J Conklin; P J Boor
Journal:  In Vitro Cell Dev Biol Anim       Date:  2002-10       Impact factor: 2.723

6.  In vitro effect of amifostine on haematopoietic progenitors exposed to carboplatin and non-alkylating antineoplastic drugs: haematoprotection acts as a drug-specific progenitor rescue.

Authors:  L Pierelli; G Scambia; A Fattorossi; G Bonanno; A Battaglia; A Perillo; G Menichella; P B Panici; G Leone; S Mancuso
Journal:  Br J Cancer       Date:  1998-10       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.